Main Article Content
Abstract
The purpose of the study – analysis of the clinical case "Near miss" on the basis of the Kuzbass Clinical Hospital named after S.V. Belyaev in a patient who had a new coronavirus infection COVID-19, complicated by fungal osteomyelitis of the bones of the facial skull.
Materials and methods. A 73-year-old female patient was diagnosed with chronic osteomyelitis of the frontal bone, upper, medial and lower walls of the orbit, upper jaw and body of the zygomatic bone on the right, meningitis after suffering a new coronavirus infection COVID-19 of moderate severity. This complication required surgical intervention in the scope of resection bifrontal craniotomy, sequestrectomy, resection of the anterior and posterior walls of the frontal sinus, superior and medial walls of the right orbit, posterior ethmoid cells, osteonecrectomy of the upper jaw on the right, inferior wall and inferior orbital margin of the right orbit, lateral and lower walls of the nose on the right, zygomatic bone on the right, removal 1.3; 2.1; 2.2; 2.3 teeth. The course of the postoperative period was complicated by purulent meningitis. In the postoperative period, the patient was in the anesthesiology-reanimation department for 31 days, of which the first three days she was on prolonged mechanical ventilation, then she was transferred to spontaneous breathing.
Results. Timely detected multidisciplinary lesion, observation of the patient with the involvement of doctors of maxillofacial surgery, neurosurgeons, otorhinolaryngologists, ophthalmologists-surgeons, neurologists, cardiologists, and anesthesiologists-resuscitators, made it possible to timely identify the resulting fungal infection and perform surgery.
Conclusions. The presented clinical case is a vivid example of one of the serious complications of the new coronavirus infection COVID-19. Viral pneumonia increases the susceptibility of patients to bacterial and fungal superinfections, which complicates the clinical course of the disease in many critically ill patients. Given the difficulties associated with the diagnosis and management of this category of patients, there is an urgent need to study the epidemiology and characteristics of this secondary infection.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018; 6: 782-792
Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020; 71: 1367-1376
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382: 1708-1720
Koehler P, Cornely OA, Böttiger BW, et al. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020; 63: 528-534
Alanio A, Dellière S, Fodil S, Bretagne S, Mégarbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020; 8: e48–49
van Arkel ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, Verweij PE, Bentvelsen RG. COVID-19 associated pulmonary aspergillosis. Am J Respir Crit Care Med. 2020; 202: 132-135
Arastehfar A, Carvalho A, van de Veerdonk FL, et al. COVID-19 associated pulmonary aspergillosis (CAPA) – from immunology to treatment. J Fungi (Basel). 2020; 6: 91
Gangneux JP, Reizine F, Guegan H, et al. Is the COVID-19 pandemic a good time to include aspergillus molecular detection to categorize aspergillosis in ICU patients? A monocentric experience. J Fungi (Basel). 2020; 10: 105
Bartoletti M, Pascale R, Cricca M, et al. Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. Clin Infect Dis. 2020; published online July 28. DOI: 10.1093/cid/ciaa1065
White PL, Dhillon R, Cordey A, et al. A national strategy to diagnose COVID-19 associated invasive fungal disease in the ICU. Clin Infect Dis. 2020; published online Aug 29. DOI: 10.1093/cid/ciaa1298
Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020; 71: 762-768
Stanzani M, Vianelli N, Cavo M, Kontoyiannis DP, Lewis RE. Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies. J Infect. 2019; 78: 484-490
Wahidi MM, Lamb C, Murgu S, et al. American Association for Bronchology and Interventional Pulmonology (AABIP) statement on the use of bronchoscopy and respiratory specimen collection in patients with suspected or confirmed COVID-19 infection. J Bronchology Interv Pulmonol. 2020; 27: e52-54
Torrego A, Pajares V, Fernández-Arias C, Vera P, Mancebo J. Bronchoscopy in patients with COVID-19 with invasive mechanical ventilation: a single-center experience. Am J Respir Crit Care Med. 2020; 202: 284-287
Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020; 581: 465-469
Bullard J, Dust K, Funk D, et al. Predicting infectious SARS-CoV-2 from diagnostic samples. Clin Infect Dis. 2020; published online May 22. DOI: 10.1093/cid/ciaa638
White PL. ECMM webinar on COVID-19 associated aspergillosis: point of care diagnosis – soon reality? Oct 1, 2020. https://www. youtube.com/watch?v=xY595itDbVo